Risk factors for ocular graft-versus-host disease: A systematic review and meta-analysis
PLOS One · 2025
DOI: 10.1371/journal.pone.0324703 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, 2025. Verfasst von Yuanyuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Eye Diseases. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinling Hospital of Nanjing, National Natural Science Foundation of China NSFC, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
AIM Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important treatment for blood disease, and ocular graft-versus-host disease (oGVHD) is a common complication that significantly affects the quality of life of patients. Currently, the risk factors for oGVHD are still controversial.
Methods
To provide a scientific foundation for the prevention of oGVHD in patients undergoing allo-HSCT, studies on the factors influencing the development of oGVHD were searched in PubMed, Embase, Web of Science, Sino Med, the Cochrane Library, CIKI, the Wanfang Database, and the VIP Database from database construction to May 2024.
Results
Seventeen studies included 4,501 patients who received allo-HSCT, of which 1,526 were diagnosed with oGVHD, involving 22 factors. The overall prevalence of oGVHD was 37.8%.[95% CI (0.294, 0.463)].The prevalence of oGVHD based on the diagnostic criteria recommended by the National Institutes of Health was 46.7% [95% CI (0.390, 0.545)], that of the International Chronic oGVHD Group was 33.7% [95% CI (0.167, 0.506)], and that of self-defined diagnostic criteria was 32.0% [95% CI (0.184, 0.457)]. According to the meta-analysis, elderly patients [OR=1.10, 95% CI (1.00, 1.20)], female donors [OR=1.48, 95% CI (1.20, 1.83)], matched-relative donors (MRD) [OR=1.50, 95% CI (1.22, 1.83)], peripheral hematopoietic stem cells (PBSCs) [OR=1.81, 95% CI (1.38, 2.39)], acute graft-versus-host disease (aGVHD) [OR=1.74, 95% CI (1.29, 2.35)], chronic graft-versus-host disease (cGVHD) [OR=3.04, 95% CI (1.82, 5.08)], oral [OR=13.83, 95% CI (5.09, 37.56)] and skin graft-versus-host disease (GVHD) [OR=5.55, 95% CI (2.41,12.79)] were risk factors for the development of oGVHD (P < 0.0 5).
Conclusion
According to our systematic review and meta-analysis, the factors listed above are associated with oGVHD and can serve as early warning signs for clinicians in identifying high-risk populations eligible for early intervention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
ORCID-Profile: Feng Li
Förderung
- Jinling Hospital of Nanjing
- National Natural Science Foundation of China NSFC
- Innovative Research Group Project of the National Natural Science Foundation of China
- Jingling hospital
Zitieren
APA
Wang, Y., Min, Y., Sun, Y., Xue, M., & Li, F. (2025). Risk factors for ocular graft-versus-host disease: A systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0324703
Vancouver
Wang Y, Min Y, Sun Y, Xue M, Li F. Risk factors for ocular graft-versus-host disease: A systematic review and meta-analysis. PLOS One. 2025. doi:10.1371/journal.pone.0324703
BibTeX
@article{Wang2025,
author = {Wang, Yuanyuan and Min, Yuan and Sun, Yanfei and Xue, Mengxin and Li, Feng},
title = {Risk factors for ocular graft-versus-host disease: A systematic review and meta-analysis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324703}
}
EUVIMED